BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Staging
10 results:

  • 1. H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma.
    Ricci C; Ambrosi F; Franceschini T; Giunchi F; Maracci ME; Sirolli M; Orsatti A; Chiarucci F; Franchini E; Borsato M; Massari F; Mollica V; Bianchi FM; Colecchia M; Acosta AM; Fiorentino M
    Pathol Res Pract; 2023 Feb; 242():154337. PubMed ID: 36706585
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Testis cancer Care in North Carolina: Implications for Real-World Evidence and cancer Surveillance.
    McMahon S; Zhou X; Baggett CD; Bjurlin MA; Chen RC; Riggs SB; Litwin MS; Milowsky MI; Wallen EM; Tan HJ
    Clin Genitourin Cancer; 2022 Aug; 20(4):307-318. PubMed ID: 35581139
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Increasing incidence of cancer and stage migration towards advanced disease in children and young adolescents in the Netherlands, 1990-2017.
    Reedijk AMJ; Kremer LC; Visser O; Lemmens V; Pieters R; Coebergh JWW; Karim-Kos HE
    Eur J Cancer; 2020 Jul; 134():115-126. PubMed ID: 32521425
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Readability of American online patient education materials in urologic oncology: a need for simple communication.
    Pruthi A; Nielsen ME; Raynor MC; Woods ME; Wallen EM; Smith AB
    Urology; 2015 Feb; 85(2):351-6. PubMed ID: 25623686
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage I nonseminomatous testicular cancer.
    Moul JW; Snow PB; Fernandez EB; Maher PD; Sesterhenn IA
    J Urol; 1995 May; 153(5):1674-7. PubMed ID: 7715008
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.
    Loehrer PJ; Johnson D; Elson P; Einhorn LH; Trump D
    J Clin Oncol; 1995 Feb; 13(2):470-6. PubMed ID: 7531223
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors.
    Fernandez EB; Moul JW; Foley JP; Colon E; McLeod DG
    Urology; 1994 Oct; 44(4):548-52. PubMed ID: 7941194
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy of radiographic chest imaging in patients with testicular cancer.
    Fernandez EB; Colon E; McLeod DG; Moul JW
    Urology; 1994 Aug; 44(2):243-8; discussion 248-9. PubMed ID: 8048200
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection.
    Herr HW; Whitmore WF; Sogani PC; Watson RC; Fair WR
    J Urol; 1986 Mar; 135(3):500-3. PubMed ID: 3944894
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Correlation of serum tumor markers and lymphangiography with degrees of nodal involvement in surgical stage II testis cancer.
    Vugrin D; Whitmore WF; Nisselbaum J; Watson RC
    J Urol; 1982 Apr; 127(4):683-4. PubMed ID: 6175770
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.